J&J files for emergency use of vaccine jab in PH
US pharmaceutical firm Johnson & Johnson (“J&J”) filed its application for emergency use authorization of its single-dose COVID-19 vaccine in the Philippines last March 31.
Once the application has been authorized by the country’s FDA, J&J will be the fifth vaccine manufacturer to get regulatory approval, following Pfizer-BioNTech, Oxford-AstraZeneca, Sinovac, and Gamaleya-Sputnik V.
Food and Drug Administration (FDA) Director General Eric Domingo said that the application “is now under evaluation.” Vaccine czar Carlito Galvez has previously stated that they’re hoping to finalize the supply agreement with J&J.
Related news
- Filipino seafarers one of Philippines’ economic drivers · 8 Jan 2020
- Philippines to be leader in personalized process optimization · 7 Jan 2020
- Access to information key challenge to contact centers · 6 Jan 2020
Disclosure: Outsource Accelerator uses AI tools in the backend of its editorial workflow. Every article is reviewed and verified by a human editor before publication.
Stay ahead of the outsourcing industry. Join thousands of business leaders who rely on Outsource Accelerator for the news, trends, and expert insights that matter. Subscribe to our free newsletter and never miss an update.
